In experimental models, the NF-κB signaling pathway contributes to the development of cancer-associated cachexia [38], and in patients, a recent study found that the expression of the NF-κB p65 subunit was 25% higher in the skeletal muscle of those with gastric cancer compared to the controls [37]. The gene discussed is NFKB1; the disease is cancer.